Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pigmented Villonodular Synovitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableLooking for participantsNCT07075471
What this trial is testing

MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Who this might be right for
Tenosynovial Giant Cell Tumor
Deciphera Pharmaceuticals, LLC 100
Testing effectiveness (Phase 2)Study completedNCT01261429
What this trial is testing

Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)

Who this might be right for
Pigmented Villonodular Synovitis
Centre Leon Berard 50
Not applicableLooking for participantsNCT07503821
What this trial is testing

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Who this might be right for
Synovitis Villonodular
Nantes University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
St. Jude Children's Research Hospital 139
Early research (Phase 1)Looking for participantsNCT02390752
What this trial is testing

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Who this might be right for
Neurofibroma, PlexiformPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, Acute+1 more
National Cancer Institute (NCI) 54
Not applicableStudy completedNCT04952896
What this trial is testing

Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease

Who this might be right for
Synovial DiseasesPigmented Villonodular SynovitisGout+1 more
Peking University Third Hospital 350
Large-scale testing (Phase 3)Active Not RecruitingNCT05059262
What this trial is testing

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisGiant Cell Tumor of Tendon Sheath+2 more
Deciphera Pharmaceuticals, LLC 123
Testing effectiveness (Phase 2)Study completedNCT04703322
What this trial is testing

Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Who this might be right for
Tenosynovial Giant Cell Tumor
Daiichi Sankyo Co., Ltd. 9
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Early research (Phase 1)Ended earlyNCT02673736
What this trial is testing

PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Who this might be right for
Solid TumorsTenosynovial Giant Cell TumorSynovitis, Pigmented Villonodular
Plexxikon 11
Early research (Phase 1)UnknownNCT05277454
What this trial is testing

Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT

Who this might be right for
Advanced Malignant Solid TumorsTGCT
Hutchison Medipharma Limited 113
Not applicableLooking for participantsNCT04635111
What this trial is testing

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Who this might be right for
HepatotoxicityTenosynovial Giant Cell Tumor
Daiichi Sankyo 30
Post-approval studies (Phase 4)Study completedNCT04526704
What this trial is testing

Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib

Who this might be right for
Tenosynovial Giant Cell Tumor
Daiichi Sankyo 32